Familial melanoma: Clinical factors associated with germline CDKN2A mutations according to the number of patients affected by melanoma in a family
✍ Scribed by Maubec, Eve; Chaudru, Valérie; Mohamdi, Hamida; Blondel, Christophe; Margaritte-Jeannin, Patricia; Forget, Sébastien; Corda, Eve; Boitier, Françoise; Dalle, Stéphane; Vabres, Pierre; Perrot, Jean-Luc; Lyonnet, Dominique Stoppa; Zattara, Hélène; Mansard, Sandrine; Grange, Florent; Leccia, Marie-Thérèse; Vincent-Fetita, Lynda; Martin, Ludovic; Crickx, Béatrice; Joly, Pascal; Thomas, Luc; Bressac-de Paillerets, Brigitte; Avril, Marie-Françoise; Demenais, Florence
- Book ID
- 119263311
- Publisher
- Elsevier Science
- Year
- 2012
- Tongue
- English
- Weight
- 285 KB
- Volume
- 67
- Category
- Article
- ISSN
- 1097-6787
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Germline mutations in the __CDKN2A__ gene have been shown to predispose individuals to cutaneous malignant melanoma. Here, we describe three melanoma‐prone families and one isolated patient affected by multiple melanoma who carried a tandem germline mutation of __CDKN2A__ at the nucleot
Germline mutations within the CDKN2A gene, coding for the cyclin-dependent kinase inhibitor p16, have been detected by screening in 8% of Swedish families with an inheritance of cutaneous melanoma (FMM) and dysplastic nevus syndrome (DNS). Contrastingly, the closely related gene CDKN2B had no diseas
## Abstract The __CDKN2A/ARF__ genes have been associated with increased risk of malignant melanoma (MM) in families with multiple members affected by disease and in families characterized by the constellation of breast cancer and MM. The exact contribution of __CDKN2A/ARF__ to disease risk remains